ART'S-WAY MANUFACTURING CO (ARTW)

US0431681032 - Common Stock

1.95  -0.08 (-3.94%)

After market: 1.94 -0.01 (-0.51%)

Fundamental Rating

2

Overall ARTW gets a fundamental rating of 2 out of 10. We evaluated ARTW against 131 industry peers in the Machinery industry. ARTW has a bad profitability rating. Also its financial health evaluation is rather negative. ARTW is valued expensive and it does not seem to be growing.



Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ARTW has reported negative net income.
ARTW had a positive operating cash flow in the past year.
In multiple years ARTW reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: ARTW reported negative operating cash flow in multiple years.

1.2 Ratios

ARTW has a worse Return On Assets (-5.53%) than 74.02% of its industry peers.
ARTW has a Return On Equity of -11.52%. This is in the lower half of the industry: ARTW underperforms 74.02% of its industry peers.
Industry RankSector Rank
ROA -5.53%
ROE -11.52%
ROIC N/A
ROA(3y)0.84%
ROA(5y)-3.2%
ROE(3y)1.74%
ROE(5y)-5.6%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

ARTW has a Gross Margin (27.40%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of ARTW has grown nicely.
ARTW does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y38.33%
GM growth 5Y9.77%

More info and screens

2

2. Health

2.1 Basic Checks

ARTW does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ARTW has more shares outstanding
Compared to 5 years ago, ARTW has more shares outstanding
The debt/assets ratio for ARTW is higher compared to a year ago.

2.2 Solvency

ARTW has an Altman-Z score of 2.41. This is not the best score and indicates that ARTW is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of ARTW (2.41) is worse than 62.20% of its industry peers.
The Debt to FCF ratio of ARTW is 7.29, which is on the high side as it means it would take ARTW, 7.29 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ARTW (7.29) is comparable to the rest of the industry.
ARTW has a Debt/Equity ratio of 0.62. This is a neutral value indicating ARTW is somewhat dependend on debt financing.
The Debt to Equity ratio of ARTW (0.62) is worse than 66.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 7.29
Altman-Z 2.41
ROIC/WACCN/A
WACC9.65%

2.3 Liquidity

ARTW has a Current Ratio of 1.55. This is a normal value and indicates that ARTW is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.55, ARTW is doing worse than 76.38% of the companies in the same industry.
A Quick Ratio of 0.37 indicates that ARTW may have some problems paying its short term obligations.
The Quick ratio of ARTW (0.37) is worse than 96.06% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 0.37

More info and screens

2

3. Growth

3.1 Past

The earnings per share for ARTW have decreased strongly by -252.49% in the last year.
The Revenue has been growing slightly by 0.34% in the past year.
The Revenue has been growing by 8.95% on average over the past years. This is quite good.
EPS 1Y (TTM)-252.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.4%
Revenue 1Y (TTM)0.34%
Revenue growth 3Y10.55%
Revenue growth 5Y8.95%
Sales Q2Q%-27.64%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ARTW. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ARTW indicates a slightly more expensive valuation: ARTW is more expensive than 68.50% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, ARTW is valued cheaper than 94.49% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.72
EV/EBITDA 26.46

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ARTW does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ART'S-WAY MANUFACTURING CO

NASDAQ:ARTW (1/6/2025, 6:18:11 PM)

After market: 1.94 -0.01 (-0.51%)

1.95

-0.08 (-3.94%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)10-09 2024-10-09
Earnings (Next)02-20 2025-02-20
Inst Owners3.05%
Inst Owner Change0%
Ins Owners10.62%
Ins Owner Change0.66%
Market Cap9.81M
Analysts100
Price TargetN/A
Short Float %0.34%
Short Ratio0.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.32
P/FCF 9.72
P/OCF 5.18
P/B 0.87
P/tB 0.87
EV/EBITDA 26.46
EPS(TTM)-0.23
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.2
FCFY10.28%
OCF(TTM)0.38
OCFY19.32%
SpS6.14
BVpS2.24
TBVpS2.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.53%
ROE -11.52%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.4%
FCFM 3.26%
ROA(3y)0.84%
ROA(5y)-3.2%
ROE(3y)1.74%
ROE(5y)-5.6%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.47%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y38.33%
GM growth 5Y9.77%
F-Score4
Asset Turnover1.32
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 7.29
Debt/EBITDA 13.53
Cap/Depr 102.02%
Cap/Sales 2.87%
Interest Coverage N/A
Cash Conversion 366.14%
Profit Quality N/A
Current Ratio 1.55
Quick Ratio 0.37
Altman-Z 2.41
F-Score4
WACC9.65%
ROIC/WACCN/A
Cap/Depr(3y)140.76%
Cap/Depr(5y)110.29%
Cap/Sales(3y)3.81%
Cap/Sales(5y)3.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-252.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.4%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.34%
Revenue growth 3Y10.55%
Revenue growth 5Y8.95%
Sales Q2Q%-27.64%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-123.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y217.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y311.91%
OCF growth 3YN/A
OCF growth 5YN/A